Latest News & Features
Americas
The US Supreme Court has agreed to hear the biosimilars dispute between Amgen and Sandoz. 16 January 2017
Americas
Sanofi and Genzyme have filed a complaint against Mylan for patent infringement over the drug Aubagio, a treatment for relapsing forms of multiple sclerosis. 13 January 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling by a district court giving a win to Eli Lilly in a patent case against Teva. 13 January 2017
Americas
Rochester Drug Co-operative, a wholesaler serving community retail pharmacy and home healthcare dealers, has filed a class action complaint against Shire and Actavis in a competition case centring on ADHD drug Intuniv. 12 January 2017
Americas
A US District Court has denied Sanofi and Regeneron’s motion to suspend an injunction which was obtained by Amgen earlier this month. 12 January 2017
Americas
Squire Patton Boggs has hired Thomas Anderton as of counsel in its intellectual property and technology practice in San Francisco. 12 January 2017
Americas
Japan-based Takeda Pharmaceutical has acquired Ariad Pharmaceuticals, a company which develops small-molecule medicines for cancer treatments, for $5.2 billion. 11 January 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed and remanded a patent dispute centring on a cannulated scalpel, a method of knee surgery. 11 January 2017
Americas
Pharmaceutical research company Phigenix lost an appeal at the US Court of Appeals for the Federal Circuit yesterday, after the court found that the company lacked standing in a patent case against ImmunoGen. 10 January 2017
Biotechnology
Several changes have been made to Italy’s regulatory landscape for biosimilars, as Luca Tosoni of Covington & Burling reports. 10 January 2017